Horizon Therapeutics
Irish tax-registered pharmaceutical / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Horizon Therapeutics?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Horizon Therapeutics was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.[3] Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales.[4] Amgen acquired the company in October 2023.[5]
Quick Facts Formerly, Company type ...
![]() | |
Formerly | Horizon Pharma plc |
---|---|
Company type | Subsidiary |
Nasdaq: HZNP | |
Industry | Pharmaceutical |
Founded | 2005; 19 years ago (2005)[1] |
Headquarters |
|
Key people | Timothy P. Walbert (Chairman, President & CEO) Paul W. Hoelscher (CFO) |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 2,115 (2022) |
Parent | Amgen |
Website | horizontherapeutics |
Footnotes / references [2] |
Close